Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Reprod Fertil Dev ; 29(6): 1130-1143, 2017 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-27166213

RESUMEN

Fipronil is an insecticide widely used in agriculture, veterinary medicine and public health that has recently been listed as a potential endocrine disrupter. In the present study we evaluated the effects of perinatal exposure to fipronil during the period of sexual brain differentiation and its later repercussions on reproductive parameters in male rats. Pregnant rats were exposed (via gavage) to fipronil (0.03, 0.3 or 3mgkg-1) from Gestational Day 15 until Postnatal Day 7. Fipronil exposure did not compromise the onset of puberty. In adulthood, there was no effect on organ weight or sperm production. Furthermore, there were no adverse effects on the number of Sertoli cells per seminiferous tubule, testicular and epididymal histomorphometry or histopathology or expression patterns of androgen receptor in the testis. Similarly, no changes were observed in the sexual behaviour or hormone levels. However, in rats exposed to fipronil, changes in sperm motility were observed, with a decrease in motile spermatozoa and an increase in non-mobile spermatozoa, which can compromise sperm quality in these rats. Perinatal exposure to fipronil has long-term effects on sperm parameters, and the epididymis can be a target organ. Additional studies should be undertaken to identify the mechanisms by which fipronil affects sperm motility.


Asunto(s)
Astenozoospermia/inducido químicamente , Disruptores Endocrinos/toxicidad , Epidídimo/efectos de los fármacos , Insecticidas/toxicidad , Lactancia , Exposición Materna/efectos adversos , Pirazoles/toxicidad , Administración Oral , Animales , Astenozoospermia/patología , Forma de la Célula/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Disruptores Endocrinos/administración & dosificación , Epidídimo/patología , Femenino , Desarrollo Fetal/efectos de los fármacos , Insecticidas/administración & dosificación , Masculino , Neurogénesis/efectos de los fármacos , Tamaño de los Órganos/efectos de los fármacos , Embarazo , Pirazoles/administración & dosificación , Ratas Wistar , Túbulos Seminíferos/efectos de los fármacos , Túbulos Seminíferos/patología , Motilidad Espermática/efectos de los fármacos , Espermatogénesis/efectos de los fármacos , Testículo/efectos de los fármacos , Testículo/patología
2.
J Appl Toxicol ; 37(9): 1065-1072, 2017 09.
Artículo en Inglés | MEDLINE | ID: mdl-28326570

RESUMEN

Betamethasone is the drug of choice for antenatal treatment, promoting fetal lung maturation and decreasing mortality. Previous studies in rats reported male programming and alteration in sperm parameters and sexual behavior following intrauterine betamethasone exposure. The impact on the female reproductive development is not known. In this study, rat female offspring was assessed for sexual development, morphophysiology of the reproductive tract and fertility after maternal exposure to 0.1 mg kg-1 of betamethasone or vehicle on gestational days 12, 13, 18 and 19. The treatment promoted reduction of litter weight on postnatal day 1, morphological masculinization in females, delay in the age of puberty onset, reduction in estrus number, increase in estrous cycle length and increase in luteinizing hormone serum levels and uterus weight. The females from the betamethasone group showed an increase of myometrial uterine area and decrease in endometrial uterine area. These animals also performed less lordosis during the sexual behavior test and showed impaired reproductive performance. The uterus showed higher contraction in the treated group as shown by a pharmacological assay. In conclusion, prenatal betamethasone exposure in rats promoted female masculinization, altered sexual development and reproductive parameters. Copyright © 2017 John Wiley & Sons, Ltd.


Asunto(s)
Betametasona/toxicidad , Efectos Tardíos de la Exposición Prenatal/diagnóstico , Reproducción/efectos de los fármacos , Animales , Peso Corporal , Ciclo Estral/efectos de los fármacos , Estro/efectos de los fármacos , Femenino , Fertilidad/efectos de los fármacos , Hormona Luteinizante/sangre , Masculino , Exposición Materna/efectos adversos , Tamaño de los Órganos/efectos de los fármacos , Embarazo , Ratas , Ratas Wistar , Conducta Sexual Animal/efectos de los fármacos , Útero/efectos de los fármacos
3.
An Acad Bras Cienc ; 89(3 Suppl): 2423-2432, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28746624

RESUMEN

Myracrodruon urundeuva is a plant native to Brazil, which is used by the indigenous population for the treatment of candidiasis. The aims of this study were to evaluate the antifungal activity of extract against human vaginal Candida species and evaluate the possible toxicological activities of M. urundeuva. Initially, ethanol extracts, ethyl acetate fractions, and hydroalcoholic fractions of the bark and leaf of M. urundeuva were used to determine the minimum inhibitory concentration. The extracts that showed antifungal activity were characterized by liquid chromatography and subjected to toxicity assessment. Toxic, cytotoxic, genotoxic, and mutagenic testing were performed using Allium cepa and Ames assays with the ethanol extracts of the bark and leaves. Hemolytic activity was evaluated in erythrocytes and acute toxicity in rats. The ethanol bark extracts showed best activity against Candida albicans, C. krusei, and C. tropicalis ATCC (4-512 µg/mL). Chemical characterization indicated the presence of flavonoids and tannins in the extracts. Hemolytic activity, genotoxicity, and mutagenicity were not observed. The results of the Ames and A. cepa tests were also in agreement, ethanol bark extracts and ethanol leaf extracts of M. urundeuva showed absence of mutagenic activity. Similar results were observed in the A. cepa assay and acute toxicity test in rats. M. urundeuva bark extracts showed potential for the treatment of vaginal infections caused Candida species, as a topical.


Asunto(s)
Anacardiaceae/química , Antifúngicos/farmacología , Candida albicans/efectos de los fármacos , Extractos Vegetales/farmacología , Hojas de la Planta/química , Animales , Antifúngicos/aislamiento & purificación , Brasil , Femenino , Flavonoides/farmacología , Humanos , Pruebas de Sensibilidad Microbiana , Corteza de la Planta/química , Ratas , Taninos/farmacología
4.
Reprod Toxicol ; 63: 125-34, 2016 08.
Artículo en Inglés | MEDLINE | ID: mdl-27247242

RESUMEN

Antenatal betamethasone is used for accelerating fetal lung maturation for women at risk of preterm birth. Altered sperm parameters were reported in adult rats after intrauterine exposure to betamethasone. In this study, male rat offspring were assessed for reproductive development after dam exposure to betamethasone (0.1mg/kg) or vehicle on Days 12, 13, 18 and 19 of pregnancy. The treatment resulted in reduction in the offspring body weight, delay in preputial separation, decreased seminal vesicle weight, testosterone levels and fertility, and increased testicular weight. In the testis, morphologically abnormal seminiferous tubules were observed, characterized by an irregular cell distribution with Sertoli cell that were displaced towards the tubular lumen. These cells expressed both Connexin 43 (Cx43) and Proliferative Nuclear Cell Antigen (PCNA). In conclusion, intrauterine betamethasone treatment appears to promote reproductive programming and impairment of rat sexual development and fertility due to, at least in part, unusual testicular disorders.


Asunto(s)
Betametasona/toxicidad , Intercambio Materno-Fetal , Efectos Tardíos de la Exposición Prenatal , Desarrollo Sexual/efectos de los fármacos , Animales , Peso Corporal/efectos de los fármacos , Conexina 43/metabolismo , Femenino , Fertilidad/efectos de los fármacos , Desarrollo Fetal/efectos de los fármacos , Masculino , Embarazo , Antígeno Nuclear de Célula en Proliferación/metabolismo , Ratas Wistar , Testículo/efectos de los fármacos , Testículo/metabolismo
5.
An. acad. bras. ciênc ; 89(3,supl): 2423-2432, 2017. tab
Artículo en Inglés | LILACS | ID: biblio-886812

RESUMEN

ABSTRACT Myracrodruon urundeuva is a plant native to Brazil, which is used by the indigenous population for the treatment of candidiasis. The aims of this study were to evaluate the antifungal activity of extract against human vaginal Candida species and evaluate the possible toxicological activities of M. urundeuva. Initially, ethanol extracts, ethyl acetate fractions, and hydroalcoholic fractions of the bark and leaf of M. urundeuva were used to determine the minimum inhibitory concentration. The extracts that showed antifungal activity were characterized by liquid chromatography and subjected to toxicity assessment. Toxic, cytotoxic, genotoxic, and mutagenic testing were performed using Allium cepa and Ames assays with the ethanol extracts of the bark and leaves. Hemolytic activity was evaluated in erythrocytes and acute toxicity in rats. The ethanol bark extracts showed best activity against Candida albicans, C. krusei, and C. tropicalis ATCC (4-512 µg/mL). Chemical characterization indicated the presence of flavonoids and tannins in the extracts. Hemolytic activity, genotoxicity, and mutagenicity were not observed. The results of the Ames and A. cepa tests were also in agreement, ethanol bark extracts and ethanol leaf extracts of M. urundeuva showed absence of mutagenic activity. Similar results were observed in the A. cepa assay and acute toxicity test in rats. M. urundeuva bark extracts showed potential for the treatment of vaginal infections caused Candida species, as a topical.


Asunto(s)
Humanos , Animales , Femenino , Ratas , Candida albicans/efectos de los fármacos , Extractos Vegetales/farmacología , Hojas de la Planta/química , Anacardiaceae/química , Antifúngicos/farmacología , Taninos/farmacología , Flavonoides/farmacología , Brasil , Pruebas de Sensibilidad Microbiana , Corteza de la Planta/química , Antifúngicos/aislamiento & purificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA